Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1994 Sep 24;309(6957):795–796. doi: 10.1136/bmj.309.6957.795

Use of beta 2 agonists in asthma: much ado about nothing? Adverse effects are not proved.

R W Fuller 1
PMCID: PMC2540979  PMID: 7950573

Full text

PDF
795

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Britton M. G., Earnshaw J. S., Palmer J. B. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group. Eur Respir J. 1992 Oct;5(9):1062–1067. [PubMed] [Google Scholar]
  2. Castle W., Fuller R., Hall J., Palmer J. Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. BMJ. 1993 Apr 17;306(6884):1034–1037. doi: 10.1136/bmj.306.6884.1034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Mullen M., Mullen B., Carey M. The association between beta-agonist use and death from asthma. A meta-analytic integration of case-control studies. JAMA. 1993 Oct 20;270(15):1842–1845. [PubMed] [Google Scholar]
  4. Pearlman D. S., Chervinsky P., LaForce C., Seltzer J. M., Southern D. L., Kemp J. P., Dockhorn R. J., Grossman J., Liddle R. F., Yancey S. W. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. N Engl J Med. 1992 Nov 12;327(20):1420–1425. doi: 10.1056/NEJM199211123272004. [DOI] [PubMed] [Google Scholar]
  5. Picado C., Ramis I., Rosellò J., Prat J., Bulbena O., Plaza V., Montserrat J. M., Gelpí E. Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients. Am Rev Respir Dis. 1992 Jan;145(1):65–69. doi: 10.1164/ajrccm/145.1.65. [DOI] [PubMed] [Google Scholar]
  6. Sears M. R., Taylor D. R., Print C. G., Lake D. C., Li Q. Q., Flannery E. M., Yates D. M., Lucas M. K., Herbison G. P. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet. 1990 Dec 8;336(8728):1391–1396. doi: 10.1016/0140-6736(90)93098-a. [DOI] [PubMed] [Google Scholar]
  7. Speizer F. E., Doll R. A century of asthma deaths in young people. Br Med J. 1968 Jul 27;3(5612):245–246. doi: 10.1136/bmj.3.5612.245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Speizer F. E., Doll R., Heaf P. Observations on recent increase in mortality from asthma. Br Med J. 1968 Feb 10;1(5588):335–339. doi: 10.1136/bmj.1.5588.335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Spitzer W. O., Suissa S., Ernst P., Horwitz R. I., Habbick B., Cockcroft D., Boivin J. F., McNutt M., Buist A. S., Rebuck A. S. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med. 1992 Feb 20;326(8):501–506. doi: 10.1056/NEJM199202203260801. [DOI] [PubMed] [Google Scholar]
  10. Taves D. R. Minimization: a new method of assigning patients to treatment and control groups. Clin Pharmacol Ther. 1974 May;15(5):443–453. doi: 10.1002/cpt1974155443. [DOI] [PubMed] [Google Scholar]
  11. Taylor D. R., Sears M. R., Herbison G. P., Flannery E. M., Print C. G., Lake D. C., Yates D. M., Lucas M. K., Li Q. Regular inhaled beta agonist in asthma: effects on exacerbations and lung function. Thorax. 1993 Feb;48(2):134–138. doi: 10.1136/thx.48.2.134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. White S. J., Freedman L. S. Allocation of patients to treatment groups in a controlled clinical study. Br J Cancer. 1978 May;37(5):849–857. doi: 10.1038/bjc.1978.124. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES